olmetec comp 20 mg / 12.5 mg
daiichi sankyo europe gmbh - olmesartanmedoksomil / hydroklortiazid - tablett, filmdrasjert - 20 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 80 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 80 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 160 mg / 12.5 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 12.5 mg
valsartan/hydrochlorthiazid actavis 160 mg / 25 mg
actavis group ptc ehf - valsartan / hydroklortiazid - tablett, filmdrasjert - 160 mg / 25 mg
tolvaptan teva b.v. 30 mg / 90 mg
teva b.v. - tolvaptan - tablett - 30 mg / 90 mg
tolvaptan teva b.v. 30 mg / 60 mg
teva b.v. - tolvaptan - tablett - 30 mg / 60 mg
tolvaptan teva b.v. 45 mg / 15 mg
teva b.v. - tolvaptan - tablett - 45 mg / 15 mg
tolvaptan accord
accord healthcare s.l.u. - tolvaptan - upassende adh-syndrom - diuretika, - tolvaptan is indicated in adults for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion (siadh).
hydrochlorothiazide orion 12.5 mg
orion corporation - espoo - hydroklortiazid - tablett - 12.5 mg